The Italy Peptide Receptor Radionuclide Therapy (PRRT) market is estimated to be valued at US$ 591.83 Mn in 2023 and is expected to exhibit a CAGR of 8.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview:Peptide receptor radionuclide therapy or PRRT is a form of nuclear medicine therapy which is used for treating...
Peptide receptor radionuclide therapy or PRRT is a type of cancer treatment that combines peptides tagged with radioactive elements or radiopharmaceuticals. PRRT involves the use of radiolabeled molecules that target receptors on cancer cells. These receptors overexpress on neuroendocrine tumors which enables the targeting of cancer cells. The radioisotopes delivered by the peptides allows for...